Alpha generating Healthcare shorts
Healthcare
Bios continues to publish strong short ideas and recent earnings has been validating a number of their commercial short theses. They have been focused on medtech, commercial biotech, over-hyped AI, and medical supplies and tools. Recent successful calls include 1) Northwest Biotherapeutics (down 75% since initiation) - its valuation was egregious given the company’s poor financial position and numerous corporate red flags. 2) Recursion Pharmaceuticals (down 46%) - its platform lacked any clinical validation, yielded a limited number of outside partnerships with near-term milestones and demanded significant cash burn. 3) West Pharmaceutical Services (down 26%) - identified as a short because of hype surrounding GLP-1 and other biologic manufacturing.
Edition: 193
- 23 August, 2024